<SEC-DOCUMENT>0001600620-26-000020-index.html : 20260303
<SEC-HEADER>0001600620-26-000020.hdr.sgml : 20260303
<ACCEPTANCE-DATETIME>20260303161325
ACCESSION NUMBER:		0001600620-26-000020
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260227
FILED AS OF DATE:		20260303
DATE AS OF CHANGE:		20260303

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Keenan Greg
		CENTRAL INDEX KEY:			0002044006
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36421
		FILM NUMBER:		26714252

	MAIL ADDRESS:	
		STREET 1:		#140-14315 118 AVE NW
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5L 4S6

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aurinia Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001600620
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				981231763
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		#140, 14315 - 118 AVENUE
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5L 4S6
		BUSINESS PHONE:		250-744-2487

	MAIL ADDRESS:	
		STREET 1:		#140, 14315 - 118 AVENUE
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5L 4S6
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1772572400.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1772572400.html

Document 1 - RAW XML: wk-form4_1772572400.xml

</DOCUMENT>
</SEC-DOCUMENT>